Viewing Study NCT01496118


Ignite Creation Date: 2025-12-25 @ 4:52 AM
Ignite Modification Date: 2026-04-24 @ 9:09 PM
Study NCT ID: NCT01496118
Status: COMPLETED
Last Update Posted: 2022-02-02
First Post: 2011-12-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor: SCRI Development Innovations, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed/Refractory Multiple Myeloma View
None carfilzomib View
None panobinostat View